)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
HBM Healthcare Investments
HBM Healthcare Investments (HBMN) investor relations material
HBM Healthcare Investments Q2 2027 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2027 earnings summary23 Oct, 2026
Executive summary
First-half FY2026/27 net profit was CHF 176.7 million; NAV per share rose 9.8% including the CHF 9.00 dividend, while the share return was 7.8%.
Private holdings drove performance; public holdings consolidated in Q2 after a strong Q1 recovery, with liquidity supporting new and follow-on investments.
Financial highlights
Six-month net result was CHF 176.7 million versus CHF 95.6 million a year earlier; basic EPS was CHF 26.82 versus CHF 14.25.
Q2 net result was a CHF 61.6 million loss, compared with CHF 235.6 million income in Q2 a year earlier.
Net assets were CHF 1,946.0 million at 30 September 2026, up from CHF 1,844.1 million at 31 March 2026; cash and equivalents rose to CHF 278.0 million from CHF 194.4 million.
Outlook and guidance
Healthcare activity is expected to continue through financing rounds, IPOs and strategic acquisitions, but in a more selective and volatile environment; fundamentals remain supported by pharmaceutical demand for innovation.
Advanced-stage or marketed products, convincing clinical data and broad portfolio diversification are viewed as positioning the portfolio to manage market fluctuations and pursue opportunities.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from HBM Healthcare Investments
- Q1 profit of CHF 238.3m lifted NAV per share 13.0%.HBMN
Q1 2027 - Profit, NAV, and share price soared on M&A and clinical wins; CHF 9.00 dividend proposed.HBMNQ4 2026
- Nine-month profit surged to CHF 286 million, with NAV per share up 18% year-over-year.HBMNQ3 2026
- Profit surged to CHF 96 million, with NAV per share up 6.1% and strong public company gains.HBMNQ2 2026
- NAV fell 8.4% and net loss hit CHF 140 million, driven by strong Swiss franc appreciation.HBMNQ1 2026
- Profit of CHF 23 million driven by value gains in both private and public holdings.HBMNQ2 2025
- Quarterly profit of CHF 26 million led by private portfolio gains and strategic exits.HBMNQ1 2025
- Private portfolio exits and IPOs drove profit and NAV growth despite sector headwinds.HBMNQ3 2025
- Private investments drove profit and NAV growth despite sector challenges and public losses.HBMNQ4 2025
Next HBM Healthcare Investments earnings date
Q3 202722 Jan, 2027
HBM Healthcare Investments
Next HBM Healthcare Investments earnings date
Q3 202722 Jan, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)